What is Daclahep (Daclatasvir)
Daclahep is aso known as DCV, is an investigational NS5A complex inhibitor, in trials for the treatment of adults with Chronic Hepatitis C (HCV) with compensated liver disease, including genotypes 1,2,3 and 4.
Daclahep is indicated in combination with other medicinal products for the treatment of Chronic Hepatitis C (HCV)
For treatment related information, please consult your treating Physician.
Daclahep 60 mg film coated tablets
Pack Size: Film coated tablets of 28
Storage and handling
This medicinal product does not require any special storage conditions.
How do we source the Drug?
SSPWL will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.
Company that Manufactures/ Markets:
M/s Hetero Healthcare Pvt Ltd
Call: +91 07738100125 / +91 07738151650 or